{"id":4762,"date":"2012-05-25T15:03:04","date_gmt":"2012-05-25T19:03:04","guid":{"rendered":"https:\/\/www.braintumour.ca\/research_recipients\/thierry-m-muanza-research-grant-2012\/"},"modified":"2020-05-20T19:06:39","modified_gmt":"2020-05-20T23:06:39","slug":"thierry-m-muanza-research-grant-2012","status":"publish","type":"research_recipients","link":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/","title":{"rendered":"Thierry M. Muanza – Subvention de recherche 2012"},"content":{"rendered":"

Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre, Montreal, Quebec<\/p>\n

Project Title: \u00ab\u00a0Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models\u00a0\u00bb<\/h5>\n

What does the title mean?<\/h3>\n

This research aims to demonstrate that the efficacy of radiation therapy in malignant gliomas can be enhanced when administered in tandem with new combi-molecular drugs.<\/p>\n

Project Summary:<\/h3>\n

\"\"Brain tumours are one of the most difficult to treat and lethal entities in human health. The most common aggressive and deadly primary brain tumour in humans is called Glioblastoma<\/a> and has been defined as one of the most resistant to treatments which consist of radiotherapy and chemotherapy.<\/p>\n

However, recent discoveries of novel type of drug termed \u201ccombimolecules\u201d that targets both the genetic material of brain cancer cells and also one of its growth factor. We aim to demonstrate that efficacy of radiation therapy can be enhanced when it is administered in tandem with this new drug.<\/p>\n

Promising experimental results generated from the proposed studies will allow us to eventually progress the project to Phase I clinical trials in patients with refractory malignant gliomas.<\/p>\n","protected":false},"excerpt":{"rendered":"

Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: \u00ab\u00a0Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models\u00a0\u00bb<\/p>\n","protected":false},"featured_media":2242,"menu_order":0,"template":"","research_recipient_type":[285],"class_list":["post-4762","research_recipients","type-research_recipients","status-publish","has-post-thumbnail","hentry","research_recipient_type-grant-fr"],"acf":[],"yoast_head":"\nThierry M. Muanza - Subvention de recherche 2012 - Fondation canadienne des tumeurs c\u00e9r\u00e9brales<\/title>\n<meta name=\"description\" content=\"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thierry M. Muanza - Subvention de recherche 2012\" \/>\n<meta property=\"og:description\" content=\"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"Fondation canadienne des tumeurs c\u00e9r\u00e9brales\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-20T23:06:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2093\" \/>\n\t<meta property=\"og:image:height\" content=\"2271\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/\",\"url\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/\",\"name\":\"Thierry M. Muanza - Subvention de recherche 2012 - Fondation canadienne des tumeurs c\u00e9r\u00e9brales\",\"isPartOf\":{\"@id\":\"https:\/\/www.braintumour.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg\",\"datePublished\":\"2012-05-25T19:03:04+00:00\",\"dateModified\":\"2020-05-20T23:06:39+00:00\",\"description\":\"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models\",\"breadcrumb\":{\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage\",\"url\":\"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg\",\"contentUrl\":\"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg\",\"width\":2093,\"height\":2271,\"caption\":\"Thierry Muanza\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.braintumour.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Recipients\",\"item\":\"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Thierry M. Muanza – Subvention de recherche 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.braintumour.ca\/fr\/#website\",\"url\":\"https:\/\/www.braintumour.ca\/fr\/\",\"name\":\"Fondation canadienne des tumeurs c\u00e9r\u00e9brales\",\"description\":\"Notre mission est de venir en aide \u00e0 toutes les personnes touch\u00e9es par une tumeur c\u00e9r\u00e9brale au Canada par le biais de nos programmes d\u2019information, de soutien, d\u2019\u00e9ducation et de recherche.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.braintumour.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Thierry M. Muanza - Subvention de recherche 2012 - Fondation canadienne des tumeurs c\u00e9r\u00e9brales","description":"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/","og_locale":"fr_CA","og_type":"article","og_title":"Thierry M. Muanza - Subvention de recherche 2012","og_description":"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models","og_url":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/","og_site_name":"Fondation canadienne des tumeurs c\u00e9r\u00e9brales","article_modified_time":"2020-05-20T23:06:39+00:00","og_image":[{"width":2093,"height":2271,"url":"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/","url":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/","name":"Thierry M. Muanza - Subvention de recherche 2012 - Fondation canadienne des tumeurs c\u00e9r\u00e9brales","isPartOf":{"@id":"https:\/\/www.braintumour.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage"},"image":{"@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg","datePublished":"2012-05-25T19:03:04+00:00","dateModified":"2020-05-20T23:06:39+00:00","description":"Thierry M. Muanza, Jewish General Hospital Segal Cancer Centre. Project: Novel DNA damaging and anti-EGFR combi-molecule, ZR2003, to potentiate ionizing radiation in malignant glioma models","breadcrumb":{"@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#primaryimage","url":"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg","contentUrl":"https:\/\/www.braintumour.ca\/wp-content\/uploads\/2019\/11\/Thierry-Muanza.jpg","width":2093,"height":2271,"caption":"Thierry Muanza"},{"@type":"BreadcrumbList","@id":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/thierry-m-muanza-research-grant-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.braintumour.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Research Recipients","item":"https:\/\/www.braintumour.ca\/fr\/laureats_de_la_recherche\/"},{"@type":"ListItem","position":3,"name":"Thierry M. Muanza – Subvention de recherche 2012"}]},{"@type":"WebSite","@id":"https:\/\/www.braintumour.ca\/fr\/#website","url":"https:\/\/www.braintumour.ca\/fr\/","name":"Fondation canadienne des tumeurs c\u00e9r\u00e9brales","description":"Notre mission est de venir en aide \u00e0 toutes les personnes touch\u00e9es par une tumeur c\u00e9r\u00e9brale au Canada par le biais de nos programmes d\u2019information, de soutien, d\u2019\u00e9ducation et de recherche.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.braintumour.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"}]}},"_links":{"self":[{"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/research_recipients\/4762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/research_recipients"}],"about":[{"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/types\/research_recipients"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/media\/2242"}],"wp:attachment":[{"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/media?parent=4762"}],"wp:term":[{"taxonomy":"research_recipient_type","embeddable":true,"href":"https:\/\/www.braintumour.ca\/fr\/wp-json\/wp\/v2\/research_recipient_type?post=4762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}